Mercazolyl treatment of patients with thyreotoxicosis
Liashko, K.I.; Oganesova, V.T.; Minushkin, O.N.
Sovetskaia Meditsina 33(5): 146-148
1970
ISSN/ISBN: 0038-5077 PMID: 4194225 Document Number: 18729
Document emailed within 1 workday
Related Documents
Kuz'mak, N.I. 1971: Several acute-phase serum reactions in patients with thyreotoxicosis Vrachebnoe Delo 5: 105-107Detiuk, E.S.; Avgustinovich, M.S.; Baranetskaia, I.S.; Ivanova, A.I.; Ivashkevich, L.G. 1973: Histophysiology of the thyroid gland during administration of mercazolyl Problemy Endokrinologii 19(1): 69-73
Danielsson, L.; Svan, H. 1983: Atypical thyreotoxicosis in an 11-year-old girl Lakartidningen 80(39): 3592
Hartwig, W. 1975: Hyperthyroidism resulting from excess triiodotyronin i. e., T-3 thyreotoxicosis Przeglad Lekarski 32(4): 373-375
Souillet, G.; Philippe, N.; Manel, A.M.; Germain, D. 1979: Treatment of childhood acute lymphoblastic leukemia. Study of 171 patients. Value of pronostic factors for the differentiation and treatment of good and bad types. Study of 64 patients Pediatrie 34(5): 485-502
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Gatell, J.M.; Guerra, L.; Pérez-Elías, M.J.; Santamaría, J.M. 1996: Initial anti-retroviral treatment (therapeutic approach to patients without previous treatment) Enfermedades Infecciosas y Microbiologia Clinica 14(Suppl 1): 20-23
Tymejczyk, O.; Hoffman, S.; Kulkarni, S.G.; Gadisa, T.; Lahuerta, M.; Remien, R.H.; Elul, B.; El-Sadr, W.; Melaku, Z.; Nash, D. 2016: HIV Care and Treatment Beliefs among Patients Initiating Antiretroviral Treatment (ART) in Oromia, Ethiopia Aids and Behavior 20(5): 998-1008
DiBonaventura, M.daCosta.; Wagner, S.; Waters, H.; Carter, C. 2010: Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis Journal of Drugs in Dermatology: Jdd 9(8): 938-944
Usui, N. 2004: Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 52(2): 136-144
Gebremariam, M.K.; Bjune, G.A.; Frich, J.C. 2010: Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study Bmc Public Health 10: 651
Wang, Y.; Han, J.; Zhang, K.; Zhu, F.; Yang, J.; Wang, Y. 2015: Relevance between expectations before treatment, new symptoms and satisfaction after treatment in patients with pelvic organ prolapse Zhonghua Fu Chan Ke Za Zhi 50(9): 664-667
Ernst, P. 1986: Supralethal treatment and bone marrow autotransplantation in the treatment of patients with leukemia and malignant lymphoma Ugeskrift for Laeger 148(33): 2067-2071
Glasson, A.A. 1971: Surgical treatment of a cavern as part of the current treatment of patients with disseminated pulmonary tuberculosis Grudnaia Khirurgiia 13(3): 64-66
Thase, M.E.; Blomgren, S.L.; Birkett, M.A.; Apter, J.T.; Tepner, R.G. 1997: Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline Journal of Clinical Psychiatry 58(1): 16-21
Iushchuk, N.D.; Kichik, E.I.; Sergeev, V.V.; Godovannyĭ, B.A.; Tumanov, F.A. 1977: Results of treatment of dysentery patients with streptomycin-dependent vaccine in comparison with other methods of treatment Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 11: 90-94
Ncube, R.T.; Hwalima, Z.; Tshimanga, M.; Chirenda, J.; Mabaera, B.; Apollo, T. 2008: Treatment outcomes of patients on antiretrovirals after six months of treatment, Khami Clinic, Bulawayo, Zimbabwe Central African Journal of Medicine 54(1-4): 8-15
Krause, K.H.; Bohn, T.; Schmidt-Gayk, H.; Prager, P.; Ritz, E. 1978: Prophylactic treatment of epileptic patients with vitamin D2 and D3. Results of a comparative study of 86 patients Der Nervenarzt 49(3): 174-180
Piroth, L.; Grappin, M.; Waldner, A.; Sgro, C.; Duong, M.; Buisson, M.; Chavanet, P.; Portier, H. 1999: Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients Presse Medicale 28(8): 381-387
Appel, P.W.; Joseph, H.; Kott, A.; Nottingham, W.; Tasiny, E.; Habel, E. 2001: Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State Mount Sinai Journal of Medicine new York 68(1): 55-61